Morgan Stanley’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.63K | Sell |
3,411
-9,400
| -73% | -$15.5K | ﹤0.01% | 7007 |
|
2025
Q1 | $20.2K | Buy |
12,811
+8,512
| +198% | +$13.4K | ﹤0.01% | 6568 |
|
2024
Q4 | $14.4K | Buy |
4,299
+2,500
| +139% | +$8.38K | ﹤0.01% | 6674 |
|
2024
Q3 | $3.38K | Hold |
1,799
| – | – | ﹤0.01% | 7013 |
|
2024
Q2 | $3.54K | Sell |
1,799
-69
| -4% | -$136 | ﹤0.01% | 6944 |
|
2024
Q1 | $5.74K | Sell |
1,868
-1,868
| -50% | -$5.74K | ﹤0.01% | 6857 |
|
2023
Q4 | $8.7K | Buy |
3,736
+1,557
| +71% | +$3.63K | ﹤0.01% | 6869 |
|
2023
Q3 | $8.8K | Sell |
2,179
-31
| -1% | -$125 | ﹤0.01% | 6777 |
|
2023
Q2 | $9.06K | Buy |
2,210
+885
| +67% | +$3.63K | ﹤0.01% | 6844 |
|
2023
Q1 | $4.08K | Buy |
1,325
+28
| +2% | +$86 | ﹤0.01% | 7098 |
|
2022
Q4 | $3.5K | Sell |
1,297
-17
| -1% | -$46 | ﹤0.01% | 7243 |
|
2022
Q3 | $6K | Sell |
1,314
-1,025
| -44% | -$4.68K | ﹤0.01% | 7220 |
|
2022
Q2 | $16K | Sell |
2,339
-154
| -6% | -$1.05K | ﹤0.01% | 7077 |
|
2022
Q1 | $29K | Sell |
2,493
-4,599
| -65% | -$53.5K | ﹤0.01% | 6981 |
|
2021
Q4 | $131K | Sell |
7,092
-3,720
| -34% | -$68.7K | ﹤0.01% | 6287 |
|
2021
Q3 | $271K | Sell |
10,812
-470
| -4% | -$11.8K | ﹤0.01% | 5839 |
|
2021
Q2 | $713K | Buy |
11,282
+9,187
| +439% | +$581K | ﹤0.01% | 5291 |
|
2021
Q1 | $258K | Sell |
2,095
-155
| -7% | -$19.1K | ﹤0.01% | 5506 |
|
2020
Q4 | $256K | Sell |
2,250
-2,207
| -50% | -$251K | ﹤0.01% | 5466 |
|
2020
Q3 | $533K | Sell |
4,457
-7,876
| -64% | -$942K | ﹤0.01% | 4613 |
|
2020
Q2 | $1.54M | Sell |
12,333
-982
| -7% | -$122K | ﹤0.01% | 3831 |
|
2020
Q1 | $2.57M | Buy |
13,315
+12,995
| +4,061% | +$2.51M | ﹤0.01% | 3126 |
|
2019
Q4 | $106K | Buy |
320
+223
| +230% | +$73.9K | ﹤0.01% | 5635 |
|
2019
Q3 | $31K | Buy |
97
+90
| +1,286% | +$28.8K | ﹤0.01% | 5889 |
|
2019
Q2 | $3K | Sell |
7
-488
| -99% | -$209K | ﹤0.01% | 6421 |
|
2019
Q1 | $280K | Sell |
495
-756
| -60% | -$428K | ﹤0.01% | 4883 |
|
2018
Q4 | $371K | Buy |
1,251
+296
| +31% | +$87.8K | ﹤0.01% | 4985 |
|
2018
Q3 | $677K | Buy |
955
+765
| +403% | +$542K | ﹤0.01% | 4811 |
|
2018
Q2 | $111K | Sell |
190
-9
| -5% | -$5.26K | ﹤0.01% | 5715 |
|
2018
Q1 | $540K | Buy |
+199
| New | +$540K | ﹤0.01% | 4959 |
|